1.Clinicopathologic Characteristics of Papillary Microcarcinoma in the Elderly.
Won Jin KIM ; Min Jung BAE ; Yang Seon YI ; Yun Kyung JEON ; Sang Soo KIM ; Bo Hyun KIM ; In Joo KIM
Journal of Korean Thyroid Association 2013;6(1):69-74
BACKGROUND AND OBJECTIVES: Older patients show more aggressive features in papillary thyroid carcinoma (PTC). However, data about clinicopathologic features of older patients in papillary thyroid microcarcinoma (PTMC) are limited. Presently, we investigated the difference of clinicopathologic features in PTMC according to age. MATERIALS AND METHODS: A total of 820 PTMC patients (82 males, 10%; 738 females, 90%) who underwent total thyroidectomy at Pusan National University Hospital were enrolled. The patients were divided into three age groups: group 1 (44 years or younger, n=230), group 2 (45-64 years, n=513), and group 3 (65 years or older, n=77). RESULTS: Extrathyroidal extension was 33% in group 1, 32.2% in group 2, and 31.2% in group 3 (p=0.948). There was no significant difference of lymph node metastasis between the groups: N0 (59.1% vs. 67.8% vs. 70.1%), N1a (37.4% vs. 28.8% vs. 26%), and N1b (3.5% vs. 3.3% vs. 3.9%) (p=0.159). Of the 820 patients, 526 (64.1%) were diagnosed as early stage (stage I, II) PTMC and 294 (35.9%) were diagnosed as advanced stage (stage III, IV) PTMC. The proportion of patients with each stage was significantly different between the groups (p<0.001). However, there was no significantly difference in the stage over 45 years old. Of the 820 patients, 517 were evaluated BRAF(V600E) mutation. There was no difference in prevalence between each group. CONCLUSION: There was no statistically significant difference of clinicopathologic features between the groups, indicating that old age itself was not associated with unfavorable clinicopathologic features in PTMC.
Aged
;
Carcinoma
;
Carcinoma, Papillary
;
Female
;
Humans
;
Lymph Nodes
;
Male
;
Neoplasm Metastasis
;
Prevalence
;
Thyroid Gland
;
Thyroid Neoplasms
;
Thyroidectomy
2.Clinical Characteristics of Thyrotoxicosis Presented by Coronary Spasm.
Kiwon KIM ; Se Whan LEE ; Sung Wan CHUN ; Yeo Joo KIM ; Sang Jin KIM
Journal of Korean Thyroid Association 2013;6(1):64-68
BACKGROUND AND OBJECTIVES: Cardiovascular symptoms are integral and often the most predominant clinical presentation in patients with thyrotoxicosis. In patients with known or suspected coronary artery disease, myocardial ischemia and angina-like chest pain may be presented due to increase in cardiac output and cardiac contractility as a result of thyrotoxicosis. In addition, coronary spasm may result in angina-like chest pain in thyrotoxicosis patients without any fixed coronary artery stenosis. However, there are few reports about clinical characteristics of thyrotoxicosis associated with coronary artery spasm. MATERIALS AND METHODS: Coronary angiography, thyroid function test, and follow-up clinical data of patients were analyzed retrospectively. RESULTS: Twelve patients with coronary artery spasm were included over 4.5 years (male:female, 5:7). The mean age of patients was 53.3 years (range, 27 to 68), and female patients were younger than male patients (mean, 56.2 vs. 51.2 years). Only 4 patients (33%) presented typical thyrotoxic symptoms. The causes of thyrotoxicosis were Grave's disease (75%) and painless thyroiditis (25%). On coronary angiography, severe coronary spasm was observed by provocation in 6 patients, and total occlusion of right coronary artery and left circumflex artery with chest pain developed in 2 of 6 patients. After antithyroid treatment, all patients became free of chest pain. CONCLUSION: Severe coronary artery spasm can be associated with thyrotoxicosis. Thyroid function test might be a differential diagnostic test in patients with coronary artery spasm. It should be considered that thyrotoxicosis can be presented by coronary artery spasm without typical symptom of thyrotoxicosis.
Arteries
;
Cardiac Output
;
Chest Pain
;
Coronary Angiography
;
Coronary Artery Disease
;
Coronary Stenosis
;
Coronary Vasospasm
;
Coronary Vessels
;
Diagnostic Tests, Routine
;
Female
;
Follow-Up Studies
;
Humans
;
Male
;
Myocardial Ischemia
;
Spasm
;
Thorax
;
Thyroid Function Tests
;
Thyroid Gland
;
Thyroiditis
;
Thyrotoxicosis
3.Incidence & Prevalence of Hyperthyroidism and Preference for Therapeutic Modalities in Korea.
Gi Hyeon SEO ; Sun Wook KIM ; Jae Hoon CHUNG
Journal of Korean Thyroid Association 2013;6(1):56-63
BACKGROUND AND OBJECTIVES: The incidence and prevalence of hyperthyroidism has been reported to be 0.2-0.9/1000 population/year and 5-10/1000 population in foreign countries, respectively. However, there has been no nationwide survey to evaluate them in Korea. Therefore, this study was conducted to investigate the incidence and prevalence of hyperthyroidism in Korea using medicare claims data provided by the Health Insurance Review and Assessment Service. Preference for its therapeutic modalities and its change were also analyzed. MATERIALS AND METHODS: This study was performed in 308,584 (men 86,460, women 222,124) Korean patients with hyperthyroidism treated from January 2006 to June 2012. Patients with past history of hyperthyroidism were not included. RESULTS: The incidence of hyperthyroidism was 0.72/1000 population/year (men 0.40, women 1.03), and its prevalence was 3.40/1000 population (men 2.09, women 4.70) in Korea. Its peak prevalence was detected between 45 and 49 years of age. Among 177,487 patients with hyperthyroidism treated from 2007 to 2011, anti-thyroid drugs were prescribed in 97.9%, and radioiodine therapy and surgery were finally performed in 8.2% and 0.9%, respectively. The prescription of propylthiouracil (PTU) has been reduced from 63.3% in 2007 to 42.9% in 2011, but the use of methimazole (MMI) increased from 33.9% in 2007 to 54.8% in 2011. Primary physicians preferred PTU to MMI, but physicians in general hospitals preferred MMI to PTU. CONCLUSION: This is the first nationwide report to investigate the incidence and prevalence of hyperthyroidism in Korea.
Female
;
Hospitals, General
;
Humans
;
Hyperthyroidism
;
Incidence
;
Insurance, Health
;
Korea
;
Medicare
;
Methimazole
;
Prescriptions
;
Prevalence
;
Propylthiouracil
4.RAI Treatment of Distant Metastasis of Thyroid Cancer.
Journal of Korean Thyroid Association 2013;6(1):49-55
For the distant metastasis of differentiated thyroid cancers, such as papillary thyroid carcinoma, follicular thyroid carcinoma, and Hurthle cell carcinoma, radioiodine therapy is one of the standard treatment methods after total thyroidectomy. Radioiodine is accumulated in thyroid cells and thyroid cancer cells through sodium iodide symporter which is located in the membrane of cells. This molecular target specific therapy renders a better prognosis and less adverse effects. Radioiodine 131I emits gamma ray for imaging and beta ray for treatment at the same time, we can monitor patients' specific distribution of radioiodine, which let us know unexpected metastasis lesions or differentiated status of thyroid cancer cells. In this article, I reviewed practical points of view about radioiodine therapy for distant metastasis of thyroid cancers such as methods for administration of radioiodine, patients' preparation before radioiodine treatment, follow up of patients, adverse effects, and radiation safety issues.
Adenocarcinoma, Follicular
;
Beta Particles
;
Carcinoma
;
Enzyme Multiplied Immunoassay Technique
;
Follow-Up Studies
;
Gamma Rays
;
Humans
;
Ion Transport
;
Linear Energy Transfer
;
Membranes
;
Neoplasm Metastasis
;
Organothiophosphorus Compounds
;
Prognosis
;
Sodium Iodide
;
Symporters
;
Thyroid Gland
;
Thyroid Neoplasms
;
Thyroidectomy
5.Methods and Clinical Efficacy of Dosimetry-Based Treatment in Radioiodine Therapy of Thyroid Cancer.
Jin Chul PAENG ; June Key CHUNG
Journal of Korean Thyroid Association 2013;6(1):43-48
Radioiodine (RI) therapy is one of the key factors for the good prognosis of differentiated thyroid cancers. Currently, most of RI treatments are performed with predetermined fixed dose of RI, whereas strict dose adjustment is made in chemotherapy or external radiotherapy for cancer treatment. Although fixed dose methods have been practically effective in RI therapy hitherto, dose determination with individual radiation dosimetry is theoretically superior to use of empirical fixed dose, for maximization of treatment effect and minimization of adverse events. The theoretical superiority of dosimetry-based dose determination is not yet directly supported by clinical data of real world; however, indirect results support the use of dosimetry-based dose determination in several specific patient groups. In this review, the basis of dosimetry is briefly discussed with regard to necessity and practical methods. Additionally, the efficacy of dosimetry is also discussed through the data of clinical studies so far.
Humans
;
Prognosis
;
Radiometry
;
Thyroid Gland
;
Thyroid Neoplasms
6.Radioiodine Therapy: Review of the Empiric Fixed Dose Approaches and Their Selective Applications.
Journal of Korean Thyroid Association 2013;6(1):34-42
Empiric fixed dose approach is commonly adopted in the radioiodine therapy (RIT) for thyroid cancer, and considered to be a reasonably safe, simple, and easy practice. Recent clinical guidelines and articles suggested that RIT should be more selectively applied, based on risk stratification and individual treatment. However, there was no specific dose of RIT for each risk group. Application of empiric fixed dose can be needed, based on the guidelines, to improve therapeutic prognosis and radiation safety in the selected patients. In Korea, for the low risk group according to some prognostic factors, such as histology and genetic mutation, RIT can be selected, preferably using higher dose. To minimize any side effects, on the other hand, radioiodine dose can be decreased and optimized for patient's body weight, age, and kidney function. For the advanced thyroid cancer, higher fixed dose of radioiodine could be administered to improve survival and to reduce recurrence.
Body Weight
;
Hand
;
Humans
;
Kidney
;
Korea
;
Prognosis
;
Recurrence
;
Thyroid Neoplasms
7.Image-Based Dosimetry of Radionuclide Therapy.
Journal of Korean Thyroid Association 2013;6(1):26-33
Radionuclide therapies have been applied in the diverse fields of medicine, and it has been demonstrated the usefulness of it, especially in the field of oncology. Accurate dosimetric assessment is imperative during radionuclide therapy, in order to optimize the treatment efficacy for target sites and to minimize the radiation exposure for normal organ. Recent advancement in imaging technology permits the precise determination of the absorbed dose non-invasively. This imaging based dosimetry can be routinely applicable to the bedside in the near future.
Treatment Outcome
8.Korean Thyroid Association Guidelines for Patients Undergoing Radioiodine Therapy for Differentiated Thyroid Cancers (First Edition, 2012).
Won Bae KIM ; Ju Won SEOK ; Min Hee KIM ; Byung Il KIM ; Young Joo PARK ; Kyu Eun LEE ; Song Mi LEE ; Yong Sang LEE ; Kyu Hwan JUNG ; Young Suk JO ; Gi Jeong CHEON ; Jae Hoon CHUNG ; Seong Joon KANG
Journal of Korean Thyroid Association 2013;6(1):12-25
No abstract available.
Humans
;
Thyroid Gland
9.The Diagnosis and Management of Hyperthyroidism Consensus - Report of the Korean Thyroid Association.
Ka Hee YI ; Jae Hoon MOON ; In Ju KIM ; Hee Seung BOM ; Jaetae LEE ; Woong Youn CHUNG ; Jae Hoon CHUNG ; Young Kee SHONG
Journal of Korean Thyroid Association 2013;6(1):1-11
No abstract available.
Consensus
;
Hyperthyroidism
;
Thyroid Gland
10.A Case of Papillary Thyroid Carcinoma Coexistent with Thyroid Sarcoidosis.
Nan Hee CHO ; In Wook SONG ; Sun Young KWON ; Ho Chan CHO
Journal of Korean Thyroid Association 2015;8(1):121-124
Sarcoidosis is a systemic granulomatous disease that primarily affects the lung and lymphatic system of the body. The involvement of thyroid gland with sarcoidosis is uncommon. Moreover, sarcoidosis with thyroid cancer are rarely reported in the world. We encountered papillary thyroid carcinoma (PTC) coexistent with pulmonary sarcoidosis. A 35-year-old female with a medical history of pulmonary sarcoidosis visited the endocrinology department for evaluation of the thyroid nodule. Thyroid ultrasonography showed multiple markedly hypoechoic nodules in the left thyroid lobe. Then ultrasonogram-guided fine needle aspiration of left thyroid nodule was positive for papillary carcinoma. She underwent total thyroidectomy with left complete cervical lymph node dissection. The histopathology was confirmed PTC combined with non-caseating granulomatous inflammation suggesting sarcoidosis on thyroid mass and lymph node. We report here a case of PTC coexistent with thyroid involvement of pulmonary sarcoidosis.
Adult
;
Biopsy, Fine-Needle
;
Carcinoma, Papillary
;
Endocrinology
;
Female
;
Humans
;
Inflammation
;
Lung
;
Lymph Node Excision
;
Lymph Nodes
;
Lymphatic System
;
Sarcoidosis*
;
Sarcoidosis, Pulmonary
;
Thyroid Gland*
;
Thyroid Neoplasms*
;
Thyroid Nodule
;
Thyroidectomy
;
Ultrasonography